Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

PHRM 845 Module #1 > Lecture 58 - Sedative, Hypnotics, and Anxiolytics > Flashcards

Lecture 58 - Sedative, Hypnotics, and Anxiolytics Flashcards

1
Q

HISTORY AND BACKGROUND

A

Ancient: Alcohol, opioids, cannabis
1853: Bromides (K+ bromide, Bromo-Seltzer) 1903: Barbiturates widely used, abused, safety 1930s to 1960s: “Non-barbiturates”
1961: 1st benzodiazepine (BZD)
– Chlordiazepoxide –> Safer
Present Day: Large number of benzodiazepines, sedative-hypnotics, anxiolytics, anticonvulsants, muscle relaxants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Sedative

A

Calms anxiety, decreases excitement and activity, does not produce drowsiness, or impair performance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Anxiolytic

A

Antianxiety, relieves anxiety without sleep or sedation (not all anxiolytics are sedatives)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Hypnotic

A

Induces sleep, implies restful, refreshing sleep, not “hypnotized!”, natural sleep (medial use term: sleeping-inducing)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Narcotic

A

Actually means “sleep producing”, now refers to opioids or illegal drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Reticular formation

A

The reticular formation extends through the central core of the medulla oblongata, pons, midbrain
It is an intricate system composed of loosely clustered neurons in what is otherwise white matter
very complex, contains dopamine, adrenergic, serotonergic, and cholinergic neurons
regulates sleep-wake transitions and synchronization of EEG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

SLEEP PHYSIOLOGY

A

Stages of Sleep:
– Wakefulness
– Non-rapid eye movement (NREM) slow-wave sleep
– Rapid eye movement (REM) sleep
NREM sleep
– Stage 1 (dozing)
– Stage 2 (unequivocal sleep)
– Stage 3 (voltage increase, frequency decrease)
– Stage 4 (delta waves)
REM sleep (similar to awake in EEG)
Sleep Deprivation
– Total Sleep
– Delta Sleep
– REM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Factors that Regulate Sleep

A

Age: Decreases with age due to changes in activity of reticular formation
Sleep History: Rebound of REM sleep
Drug Ingestion: Acute and withdrawal produce rebound effects
Circadian Rhythms: “Normal sleep cycle”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Biological regulators of sleep

A

Neurotransmitters (almost all):
– Catecholamines (e.g., epinephrine, norepinephrine, and dopamine)
– Serotonin (5HT)
– Histamine
– Acetylcholine (ACh)
– Adenosine
– GABA (main target for current medications)
Neuromodulators:
– Growth Hormone (GH)
– Prolactin
– Cortisol
– Melatonin — “hormone of darkness”
– Endogenous Peptides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

GABAergic Neurotransmission

A

GABAA receptors
GABAB receptors
GABA transporters (GAT-1)
GABA-T (transaminase)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

GABAA receptor/chloride ion channel complex

A

targets for sedative-hypnotics
Orthosteric site: GABA (alpha1 and beta2)
Allosteric Sites
- benzodiazepine (BZD) site (alpha1 and gamma2)
-Barbiturate
-Ethanol
-Glucocorticoid
Channel pore (picrotoxin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Ligands Acting at the BZD Receptor

A

Benzodiazepines: Facilitate GABA action (e.g., alpha1-5), increase frequency, require intact GABA system (internal safety system)
Non-Benzodiazepines (Z-Hypnotics): zolpidem (Ambien®), zaleplon (Sonata®), eszopiclone (LunestaTM) – BZ1 receptors of alpha1
BZD Antagonists: flumazenil (Romazicon®), overdose treatment
Inverse BZD Agonists: B carbolines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Allosteric modulators: MOA

A

allosteric inhibitor binds to the allosteric site, preventing substrate from binding to active site because it changes the shape of the binding pocket –> little or no products made

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Modulation of the GABAA receptor

A

Ligands acting at “other” non-orthosteric sites
A. BZDs: Increase frequency of channel opening,
B. Barbiturtates (Bbt): Increase duration of channel opening, and direct effects on GABAA (high doses)
C. Alcohol: Enhances actions of GABA at GABAA receptor
D. GABA channel blockers: picrotoxin
E. Etomidate and Propofol (Diprovan; aka “milk of amnesia”): beta2 and beta3 subunit containing receptors
F. Neurosteroids (e.g., progesterone and deoxycortisone) for treating depression, etc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Benzodiazepines: Chemistry and Metabolism

A

Structure Activity Relationships of Benzodiazepines:
1 Position alkylation –> source of active metabolites
2 Position NH2 or N(CH3)2 is active; oxo is active (i.e. valium)
3 Position has decreased activity; 3-OH rapid excretion
4-Nonoxide is active
Substitution on 5-phenyl has decreased activity
7 Position with an electronegative group is good
Annealating the 1-2 bond with an “electron rich” ring (triazole or imidazole) yields high affinity and decreased half-life

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Metabolism of diazepam

A

long half-life
diazepam –> desmethyldiazepam –> oxazepam

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

BZDs with intermediate and rapid elimination rates

A

Intermediate: oxazepam, lorazepam
Rapid: alprazolam, triazolam

18
Q

Benzodiazepines: PHARMACOKINETICS - slow

A

Slow Elimination Rates: All have active metabolites
Chlordiazepoxide (Librium®): 1st benzodiazepine, used as an anxiolytic and for alcohol withdrawal, accumulation of metabolites
Diazepam (Valium®)
– Prototypical benzodiazepine, used as an anxiolytic, for alcohol withdrawal, and for
treatment of convulsive disorders (seizures), accumulation of metabolites
Flurazepam (Dalmane®)
– Used as a hypnotic, accumulation of metabolites
Clorazepate (Tranxene®)
– Used as an anxiolytic, for alcohol withdrawal, and for treatment of convulsive disorders, accumulation of metabolites
Quazepam (Doral®)
– Used as a hypnotic, accumulation of metabolites (good or bad for helping sleeping?) - BAD
Prazepam (Currently unavailable in the US) - Used as an anxiolytic

19
Q

Benzodiazepines: PHARMACOKINETICS - intermediate

A

Intermediate Elimination Rates:
Alprazolam (Xanax®)
– Withdrawal symptoms can present if abrupt discontinuation occurs, used as an anxiolytic and anesthetic
Lorazepam (Ativan®)
– Used as an anxiolytic and as a hypnotic
Clonazepam (Klonopin®)
– Tolerance may develop with prolonged use, used as an anticonvulsant
Oxazepam (Serax®)
– Used as an anxiolytic and for alcohol withdrawal
Temazepam (Restoril®)
– Used as a short-term hypnotic

20
Q

Benzodiazepines: PHARMACOKINETICS - rapid

A

Rapid Elimination Rates:
Midazolam (Versed) – Rapid anesthesia
Triazolam (Halcion®, Discontinued) – Used as a short-term hypnotic

21
Q

Benzodiazepines: Biotransformation and Therapeutics - slow elimination

A

Benzodiazepines usage:
Slow Elimination
– Accumulation
– Active Metabolites
– Drowsiness and Sedation
– Useful in patients who “wake up”

22
Q

Benzodiazepines: Biotransformation and Therapeutics - intermediate to rapid elimination

A

Intermediate to Rapid Elimination
– Preferable in patients with hepatic problems – Preferable in elderly patients
– Drugs that alter liver enzymes
– Rapid tolerance
– Rebound Insomnia

23
Q

Benzodiazepines: GENERAL CONSIDERATIONS

A

Readily absorbed (can delayed by food)
have active metabolites or are converted to active forms
Increased lipid solubility will increase speed of delivery to brain
Redistribution to highly perfused tissue may decrease duration of action
Cross placental barrier and are detected in breast milk
Extensive protein binding, but not clinically significant

24
Q

Benzodiazepines: PHARMACOLOGICAL PROPERTIES

A

Anxiolytic
Sleep Physiology
– Reduce sleep latency
– Increase total sleep time
– Increase stage 2
– Decrease REM
– Decrease stage 3 and 4 (good or bad?)
– Tolerance and rebound to delta and REM
Anticonvulsant activity
Muscle relaxant
Cardiovascular and respiratory depression (major issue when combine with other agents)
Anterograde amnesia
Unable to recall events that occurred

25
Q

Benzodiazepines: TOXICOLOGY

A

Side Effects –> dose dependent
– Sedation
§ Confusion
§ Ataxia
§ Daytime Sedation: With longer acting agents –> tolerance develops
– Weakness, Headache, Vertigo, Nausea, Paradoxical effects
Precautions and Interactions
– Other sedatives, Alcohol
– Pregnancy and breast-feeding
Drug Dependence and Abuse
– Abuse Potential –> Low vs barbiturates
– Small “Kick”: Often when in combination with other drugs of abuse

26
Q

BENZODIAZEPINE ANTAGONIST

A

Flumazenil (Romazicon®)
Therapeutic use –> treat BZD overdose
Initial Dose
– 0.2 mg IV over 30 seconds
– If desired consciousness is not obtained, increase to 0.3 mg IV over 30 seconds
Max Total Cumulative Dose – 3 mg (usual range 1-3mg)
Side Effects
– Induce Convulsions
– Panic Attacks
– Agitation
– Confusion
– Nausea and Vomiting
– Headache

27
Q

Non-benzodiazepines

A

Z-hypnotics: act at BZD binding site (BZ1 receptor)
zolpidem
zaleplon
eszopiclone

28
Q

Zolpidem (ambien, ambien CR)

A

Short-term treatment of insomnia
– With difficulty of sleep-onset
– Ambien CRTM for sleep maintenance

29
Q

Zaleplon (sonata)

A

Short-term treatment of insomnia (7-10 days) Rapid acting, Rapidly eliminated
Little tolerance or dependence

30
Q

Eszopiclone (lunesta)

A

Active enantiomer of zopiclone
– 50 times greater affinity
Treatment of insomnia
– Approved for long-term use

31
Q

“Z-Hypnotics” – Common Features

A

Metabolism
– CYP3A4 to some extent
Overdose Treatment
– Flumazenil (Romazicon®)
Side Effects
– Daytime drowsiness, dizziness, ataxia, nausea, and vomiting
– Cause less negative effects on sleep patterns vs. BZD
– Sleep-driving, sleep-cooking, sleep-eating, sleep-sex (FDA: warn your patient)

32
Q

Illicit use of sedative-hypnotics that target the benzodiazepine binding site

A

Benzodiazepines
– Flunitrazepam (C-IV): Not Available in United States; “Roofies”; DEA recommends changing to C-I; Anterograde Amnesia – Dangerous aid for sexual assault (mainly combine with alcohol)
– Clonazepam (C-IV) (research use in treating social deficits of autism): Klonopin®
Nonbenzodiazepines
– Zolpidem (C-IV): Ambien® and Ambien CRTM; “A-minus” and “Zombie Pills”; Dangerous aid for sexual assault; Teen party drug

33
Q

Barbiturates classifications - long acting

A

Anticonvulsants
– Phenobarbital (Luminal®)
– Mephobarbital (Mebaral®)

34
Q

Barbiturates classifications - short to intermediate acting

A

Sedative-Hypnotics
– Amobarbital (Amytal®)
– Butabarbital (Butisol Sodium®)
– Pentobarbital (Nembutal®)
– Secobarbital (Seconal®)
– Aprobarbital (Alurate®)

35
Q

Barbiturates classifications - ultra-short acting

A

IV Anesthetics
– Thiopental (Pentothal®)
– Methohexital (Brevital® Sodium)
– Thiamylal (Surital®)

36
Q

Barbiturates: pharmacology

A

Sleep Physiology
– Comparable to BZD: Decrease REM; Slow Deep Sleep
Cardiovascular Depression –> at high doses
Respiratory depression –> death
Enzyme interactions: compete for cytochrome P450s for metabolism; enzyme induction
Anticonvulsant, idiosyncratic excitement and pain, dependance, tolerance, abuse, withdrawal, overdose, “after effect” - hangover, accumulation

37
Q

Barbiturates: pharmacokinetics

A

Duration of Action
– Inversely proportional to lipid solubility
Decrease of Activities
– Metabolic transformations and redistribution
Ultra-Short and Short Acting
– Determined by redistribution
Anesthetics
– Determined by lipid solubility and rapid redistribution
Long Half-life
– Accumulation

38
Q

Barbiturates

A

bind to all GABAA alpha1-5; Increase the duration of channel opening; and direct effects on GABAA channel (high doses); higher risk

39
Q

Benzodiazepines

A

bind to all GABAA alpha1-5; Increase frequency of GABAA channel opening; medium risk

40
Q

Z-hypnotics

A

bind to GABAA BZ1 receptors of alpha1; Increase frequency of GABAA channel opening; lower risk

PHRM 845 Module #1 (50 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions